Stroke prediction and prevention by carotid endarterectomy: Keep an eye on the doughnut and not just the hole

Cerebrovascular Diseases

Volumn 9, Issue 6, 1999, Pages 345-350

  Hankey, Graeme J ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Carotid artery; Carotid endarterectomy; Carotid stenosis; Stroke prediction; Stroke prevention

Indexed keywords

ACETYLSALICYLIC ACID;

ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR INFLAMMATION; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; HUMAN; INFECTION; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; OCCLUSIVE CEREBROVASCULAR DISEASE; PATIENT SELECTION; PRIORITY JOURNAL; RISK FACTOR; STROKE;

ARTERIOSCLEROSIS; CAROTID ARTERY, INTERNAL; CAROTID STENOSIS; CEREBRAL INFARCTION; CEREBROVASCULAR ACCIDENT; ENDARTERECTOMY, CAROTID; HUMANS; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 0032827416     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000016010     Document Type: Article

References (60)

1. Warlow CP, Dennis MS, van Gijn J, Hankey GJ, Sandercock PAG, Bamford J, Wardlaw J: Practical Management of Stroke. Oxford Blackwell Scientific, 1996.
2. Chambers BR, Norris JW: Outcome in patients with asymptomatic neck bruits. N Engl J Med 1986;315:860-865.
3. Norris JW, Zhu CZ, Bornstein NM, Chambers BR: Vascular risks of asymptomatic carotid stenosis. Stroke 1991;22:1485-1490.
4. European Carotid Surgery Trialists' Collaborative Groups: Risk of stroke in the distribution of an asymptomatic carotid artery. Lancet 1995;345:209-212.
5. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study: Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273:1421-1428.
6. European Carotid Surgery Trialists' Collaborative Group: Randomised trial of endarterectomy for recently symptomatic carotid stenosis: Final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998;351:1379-1387.
7. European Carotid Surgery Trialists' Collaborative Group: Endarterectomy for moderate symptomatic carotid stenosis: Interim results from the MRC European Carotid Surgery Trial. Lancet 1996;347:1591-1593.
8. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Collaborators: Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445-453.
9. Barnett HJM, Warlow CP: Carotid endarterectomy and the measurement of stenosis. Stroke 1993;24:1281-1284.
10. Rothwell PM, Warlow CP: Making sense of the measurement of carotid stenosis. Cerebrovasc Dis 1996;6:54-58.
11. Writing Group: Carotid stenting and angioplasty. Stroke 1998;29:336-348.
12. Hankey GJ, Slattery JM, Warlow CP: Transient ischaemic attacks: Which patients are at high (and low) risk of serious vascular events? J Neurol Neurosurg Psychiatry 1992;5:640-652.
13. The Dutch TIA Trial Study Group: Predictors of major vascular events in patients with a transient ischaemic attack or nondisabling stroke. Stroke 1993;24:527-531.
14. Eliasziw M, Streifler JY, Fox AJ, Hachinski VC, Ferguson GG, Barnett HJM, for the North American Symptomatic Carotid Endarterectomy Trial: Significance of plaque ulceration in symptomatic patients with high-grade carotid stenosis. Stroke 1994;25:304-308.
15. Rothwell PM, Salinas R, Ferrando LA, Slattery J, Warlow CP: Does angiographic appearance of a carotid stenosis predict the risk of stroke independently of the degree of stenosis? Clin Radiol 1995;50:830-833.
16. Dippel DWJ, Koudstaal PJ, on behalf of the Dutch TIA Trial Study Group: We need stronger predictors of major vascular events in patients with a recent transient ischaemic attack or nondisabling stroke. Stroke 1997;28:774-776.
17. Hankey GJ, Slattery JM, Warlow CP: Can the long-term outcome of patients with transient ischaemic attacks be predicted accurately? J Neurol Neurosurg Psychiatry 1993;56:752-759.
18. Hankey GJ, Warlow CP: Transient Ischaemic Attacks of the Brain and Eye. London, Saunders/Baillière 1994.
19. Hankey GJ: Impact of treatment of people with transient ischaemic attacks on stroke incidence and public health. Cerebrovasc Dis 1996; 6(suppl 1):26-33.
20. Hankey GJ: The effect of treating people with reversible ischaemic attacks of the brain and eye on the incidence of stroke in Australia. Aust NZ J Med 1997;27:420-430.
21. Field PL: Asymptomatic carotid stenosis: How should it be managed? Med J Aust 1995;163: 448.
22. Dennis M, Bamford J, Sandercock P, Warlow C: Prognosis of transient ischaemic attacks in the Oxfordshire Community Stroke Project. Stroke 1990;21:848-853.
23. Ries S, Schminke U, Daffertshofer M, Schindlmayr C, Hennerici M: High intensity transient signals and carotid artery disease. Cerebrovasc Dis 1995;5:124-127.
24. Siebler M, Kleinschmidt A, Sitzer M, Steinmetz H, Freund HJ: Cerebral microembolism in symptomatic and asymptomatic high-grade internal carotid artery stenosis. Neurology 1994;44:615-618.
25. Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993;362: 801-809.
26. Davies MJ: The composition of coronary artery plaques. N Engl J Med 1997;336:1312-1314.
27. Davies MJ: Stability and instability: Two faces of coronary atherosclerosis. Circulation 1996; 94:2013-2020.
28. Burke AP, Farb A, Malcolm GT, Liang YH, Smialek J, Virmani R: Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997; 336:1276-1282.
29. Fuster V, Fallon JT, Badimon JJ, Nemerson Y: The unstable atherosclerotic plaque: Clinical significance and therapeutic intervention. Thromb Haemost 1997;78:247-255.
30. Wilcox JN, Smith KM, Schwartz SM, Gordon D: Localisation of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989;86:2839-2843.
31. Libby P: Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-2850.
32. O'Keefe JH Jr, Lavie CJ Jr, McCallister BD: Insights into the pathogenesis and prevention of coronary artery disease. Mayo Clin Proc 1995;70:69-79.
33. McIntyre M, Dominiczak AF: Nitric oxide and cardiovascular disease. Postgrad Med J 1997; 73:630-634.
34. DeGraba TJ: Expression of inflammatory mediators and adhesions molecules in human atherosclerotic plaque. Neurology 1997;49(suppl 4):15-19.
35. Nowroth PP, Handley DA, Emon CT, et al: Interleukin-1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci USA 1986; 83:3460-3464.
36. Hunt BJ, Jurd KM: Endothelial cell activation. BMJ 1998;316:1328-1329.
37. Cheng GC, Loree HM, Kamm RD, Fishbein MC, Lee RT: Distribution of circumferential stress in ruptured and stable atherosclerotic lesions: A structural analysis with histopathological correlation. Circulation 1993;87:1179-1187.
38. Danesh J, Collins R, Appleby P, Peto R: Association of fibrinogen, C-reactive protein, albumin, or leucocyte count with coronary heart disease. Meta-analysis of prospective studies. JAMA 1998;279:1477-1482.
39. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Inflammation, aspirin, and the risk of cardiovascular disease in apparently helthy men. N Engl J Med 1997;336:973-979.
40. Cook PJ, Lip GYH: Infectious agents and atherosclerotic vascular disease. Q J Med 1996;89: 727-735.
41. Gurfinkel E, Bozovich G, Daroco A, Beck E, Mautner B, for the ROXIS Study Group: Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. Lancet 1997;350:404-407.
42. Bittner V: Atherosclerosis and the immune system. Arch Intern Med 1998;158:1395-1396.
43. Danesh J, Collins R, Peto R: Chronic infections and coronary heart disease: Is there a link? Lancet 1997;350:430-436.
44. Grau AJ, Buggle F, Ziegler C, et al: Association between acute cerebrovascular ischaemia and chronic and recurrent infection. Stroke 1997; 28:1724-1729.
45. Bova IY, Bornstein NM, Korczyn AD: Acute infection as a risk factor for ischaemic stroke. Stroke 1996;27:2204-2206.
46. Wimmer ML, Sandmann-Strupp R, Saikku P, Haberl RL: Association of chlamydial infection with cerebrovascular disease. Stroke 1996;27: 2207-2210.
47. Markus HS, Mendall MA: Helicobacter pylori infection: A risk factor for ischaemic cerebrovascular disease and carotid atheroma. J Neurol Neurosurg Psychiatry 1998;64:104-107.
48. DeGraba TJ, Siren AL, Penix L, McCarron RM, Hargraves R, Sood S, Pettigrew KD, Hallenbeck JM: Increased endothelial expression of intercellular adhesion molecule-1 in symptomatic versus asymptomatic human carotid atherosclerotic plaque. Stroke 1998;29:1405-1410.
49. Yamashita K, Ouchi K, Shirai M, Gondo T, Makazawa T, Ito H: Distribution of Chlamydia pneumoniae infection in the atherosclerotic carotid artery. Stroke 1998;29:773-778.
50. Cook PJ, Honcybourne D, Lip GYH, Beevers G, Wise R, Davies P: Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia. The West Brimingham Stroke Project. Stroke 1998;29:404-410.
51. Grau AJ, Buggle F, Becher H, Zimmerman E, Spiel M, Fent T, Maiwald M, Werle E, Zorn M, Ing D, Hengel H, Hacke W: Recent bacterial and viral infection is a risk factor for cerebrovascular ischemia: Clinical and biochemical studies. Neurology 1998;50:196-203.
52. European Carotid Plaque Study Group: Carotid artery plaque composition: Relationship to clinical presentation and ultrasound B-mode imaging. Eur J Vasc Endovasc Surg 1995;10: 23-30.
53. Gronholdt M, Nordestgaard B, Nielsen T, Sillesen H: Echolucent carotid artery plaques are associated with elevated levels of fasting and postprandial triglyceride-rich lipoproteins. Stroke 1996;27:2166-2172.
54. Sterpetti A, Shultz R, Feldhaus R, Davenport K, Richardson M. Farina C, Hunter W: Ultrasonographic features of carotid plaque and the risk of subsequent neurologic deficits. Surgery 1988;104:652-660.
55. Steffen M, Gray-Weale A, Byrne K, Lusby R: Carotid artery atheroma: Ultrasound appearance in symptomatic and asymptomatic vessels. Aust NZ Surg 1989;59:529-534.
56. Iannuzzi A, Wilcosky T, Mercuri M, Rubba P, Bond M: Ultrasonographic correlates of carotid atherosclerosis in transient ischaemic attack and stroke. Stroke 1995;26:614-619.
57. Bassiouny H, Davis H, Massawa N, Gewertz B, Glagov S, Zarins C: Critical carotid stenosis: Morphologic and chemical similarity between symptomatic and asymptomatic plaques. J Vase Surg 1989;9:202-212.
58. Hatsukami T, Ferguson M, Beach K, Gordon D, Detmer P, Burns D, Alpers C, Strandness D Jr: Carotid plaque morphology and clinical events. Stroke 1997;28:95-100.
59. Joakimsen O, Bonaa KH, Stensland-Bugge E: Reproducibility of ultrasound assessment of carotid plaque occurrence, thickness, and morphology. The Tromso Study. Stroke 1997;28: 2201-2207.
60. de Bray JM, Baud JM, Dauzati M, on behalf of the Consensus Conference: Consensus concerning the morphology and the risk of carotid plaques. Cerebrovasc Dis 1997;7:289-296.